BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26944171)

  • 1. Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.
    Sesar A; Cacheiro P; López-López M; Camiña-Tato M; Quintáns B; Monroy-Jaramillo N; Alonso-Vilatela ME; Cebrián E; Yescas-Gómez P; Ares B; Rivas MT; Castro A; Carracedo A; Sobrido MJ
    J Neurol Sci; 2016 Mar; 362():321-5. PubMed ID: 26944171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
    Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.
    Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Dauvilliers Y; Spiegelman D; Greenbaum L; Fahn S; Waters CH; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
    Brain; 2021 Mar; 144(2):462-472. PubMed ID: 33349842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
    Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
    Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
    Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
    Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
    Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
    Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
    Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants in PARK loci and related genes and Parkinson's disease.
    Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
    Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
    Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
    BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
    Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
    BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9.
    Lu S; Zhou J
    Neurosci Bull; 2017 Feb; 33(1):115-117. PubMed ID: 27743341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.
    Shahmohammadibeni N; Rahimi-Aliabadi S; Jamshidi J; Emamalizadeh B; Shahmohammadibeni HA; Zare Bidoki A; Akhavan-Niaki H; Eftekhari H; Abdollahi S; Shekari Khaniani M; Shahmohammadibeni M; Fazeli A; Motallebi M; Taghavi S; Ahmadifard A; Shafiei Zarneh AE; Andarva M; Dadkhah T; Khademi E; Alehabib E; Rahimi M; Tafakhori A; Atakhorrami M; Darvish H
    Neurol Sci; 2016 May; 37(5):731-6. PubMed ID: 26732583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Han W; Liu Y; Mi Y; Zhao J; Liu D; Tian Q
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):123-34. PubMed ID: 25656566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
    Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide assessment of Parkinson's disease in a Southern Spanish population.
    Bandrés-Ciga S; Price TR; Barrero FJ; Escamilla-Sevilla F; Pelegrina J; Arepalli S; Hernández D; Gutiérrez B; Cervilla J; Rivera M; Rivera A; Ding JH; Vives F; Nalls M; Singleton A; Durán R
    Neurobiol Aging; 2016 Sep; 45():213.e3-213.e9. PubMed ID: 27393345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rs3129882/rs4248166 in
    Li J; Jian L; Huang J; Xiong N; Wang T
    Int J Neurosci; 2021 Jul; 131(7):674-680. PubMed ID: 32253955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.